Healthcare / Medical Care FacilitiesKuala Lumpur
$0.23
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $7.4M · quality 83.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$220M
P/E
22.5x
↑EV/EBITDA
12.7x
↑ROE
7.8%
↑Gross Margin
37.6%
↓Debt/Equity
0.19
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+7.8%
FCF CAGR
+17.6%
FCF margin
15.1%
FCF / Net income
1.30x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $50.4M · net income $5.9M · FCF $7.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $50.4M | $50.4M | $48.6M | $44.7M | $40.3M |
| Net Income | $5.9M | $5.9M | $4.6M | $6.2M | $5.0M |
| EBITDA | $14.4M | $14.4M | $13.3M | $14.3M | $14.6M |
| EPS | — | — | 0.00 | 0.01 | 0.01 |
| Gross Margin | 37.6% | 37.6% | 40.5% | 40.5% | 39.7% |
| Operating Margin | 13.7% | 13.7% | 15.2% | 19.8% | 10.1% |
| Net Margin | 11.6% | 11.6% | 9.4% | 14.0% | 12.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.19 | 0.19 | 0.21 | 0.48 | 0.29 |
| Current Ratio | 7.52 | 7.52 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $7.6M | $7.6M | $5.6M | $7.4M | $4.7M |
| Returns | |||||
| ROE | 7.8% | 7.8% | 6.0% | 16.7% | 14.2% |
| Valuation | |||||
| P/E | 22.50 | 22.50 | 48.94 | 82.89 | 111.93 |
| EV/EBITDA | 12.74 | 12.74 | 14.27 | 36.44 | 38.34 |
| P/B | 2.93 | 2.93 | 2.98 | 13.86 | 15.95 |
| Growth & Yield | |||||
| Revenue Growth | 3.6% | 3.6% | 8.9% | 11.0% | — |
| EPS Growth | — | — | -38.2% | 25.1% | — |
| Dividend Yield | 2.2% | 2.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+12.0%
Start / end P/E
n/dx → n/dx
EPS bridge
0.00 → n/d
Residual
+9.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.